K. Zurbonsen et al., DISSOCIATION BETWEEN PHOSPHODIESTERASE INHIBITION AND ANTIPROLIFERATIVE EFFECTS OF PHOSPHODIESTERASE INHIBITORS ON THE DAMI CELL-LINE, Biochemical pharmacology, 53(8), 1997, pp. 1141-1147
Phosphodiesterase (PDE) inhibitors were shown to inhibit proliferation
of various cell types. The present investigation was designed to stud
y the activity of selective PDE inhibitors (8-MeoMIX, milrinone, trequ
insin, rolipram, RO-201724, zaprinast, and MY-5445) on the proliferati
on of the Dami cell line in relation to their effects on cAMP levels a
nd PDE isoenzymes isolated from Dami cells. All compounds, except 8-Me
oMIX, elicited antiproliferative effects. Trequinsin, RO-201724, and M
Y-5445 (100 mu M) were found to inhibit cell growth up to 60%, 83%, an
d 85%, respectively; milrinone, rolipram and zaprinast elicited only w
eak effects (19-21% at 100 mu M). Their growth-inhibitory effects coul
d not be related to their effects on cAMP levels. In addition, althoug
h PDE type III and IV inhibitors potentiated cAMP formation due to ade
nylycyclase activation, no potentiation could be observed when conside
ring their antiproliferative effect. Separation and characterization o
f PDE of Dami cells revealed the existence of types III, IV, and V iso
enzymes. The PDE inhibition found for the PDE inhibitors could not exp
lain their antiproliferative effects. The lack of correlation with cAM
P concentrations or PDE inhibition and the high concentrations needed
to elicit antiproliferative effects suggest the implication of other p
arameters, such as cytotoxicity or lipophilicity, or other targets in
addition to PDE for the PDE inhibitors tested. Lipophilicity did not s
eem to be of importance in antiproliferative effects. In contrast, cyt
otoxic effects, in particular those of trequinsin and MY-5445, could p
artially explain their negative action on cell growth. (C) 1997 Elsevi
er Science Inc.